We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Axalta
AXTA
$7.45B
| $3.66M | 0.05% |
+140,675
| New | +$3.46M |
|
302
Bank of Hawaii
BOH
$3.14B
| $3.65M | 0.05% |
61,568
+34,366
| +126% | +$1.98M |
|
303
Old Dominion Freight Line
ODFL
$46.3B
| $3.61M | 0.05% |
139,347
-65,457
| -32% | -$1.62M |
|
|
MBLY
304
DELISTED
Mobileye N.V.
MBLY
| $3.6M | 0.05% |
+88,664
| New | +$4.16M |
|
305
Best Buy
BBY
$19B
| $3.56M | 0.05% |
91,170
+85,170
| +1,420% | +$2.99M |
|
306
Snap-on
SNA
$21.5B
| $3.55M | 0.05% |
25,939
-83,936
| -76% | -$11M |
|
|
BFYT
307
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $3.54M | 0.05% |
495,000
| – | – |
|
308
TIM SA
TIMB
$9.1B
| $3.53M | 0.05% |
158,749
+25,287
| +19% | +$601K |
|
309
Zions Bancorporation
ZION
$10.1B
| $3.5M | 0.05% |
+122,581
| New | +$3.46M |
|
310
CALL
General Motors
GM
$80.9B
| $3.49M | 0.05% |
100,000
+99,000
| +9,900% | +$3.16M |
|
|
SIAL
311
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $3.49M | 0.05% |
+25,414
| New | +$3.45M |
|
|
BRCM
312
DELISTED
BROADCOM CORP CL-A
BRCM
| $3.47M | 0.05% |
80,000
-32,193
| -29% | -$1.32M |
|
313
PUT
Dollar Tree
DLTR
$24.8B
| $3.46M | 0.05% |
+49,200
| New | +$3.1M |
|
314
Sherwin-Williams
SHW
$83.5B
| $3.46M | 0.05% |
39,444
+3,624
| +10% | +$285K |
|
315
Ulta Beauty
ULTA
$21.8B
| $3.45M | 0.05% |
+26,941
| New | +$3.3M |
|
|
ARGO
316
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $3.44M | 0.05% |
86,224
-2,978
| -3% | -$116K |
|
|
SLXP
317
PUT
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $3.42M | 0.05% |
29,700
+29,464
| +12,485% | +$3.57M |
|
|
PGRE
318
DELISTED
Paramount Group
PGRE
| $3.37M | 0.05% |
+181,104
| New | +$3.34M |
|
319
Packaging Corp of America
PKG
$22.2B
| $3.36M | 0.05% |
42,990
+7,309
| +20% | +$524K |
|
320
CALL
Quest Diagnostics
DGX
$26B
| $3.35M | 0.05% |
+50,000
| New | +$3.16M |
|
321
Cisco
CSCO
$443B
| $3.34M | 0.05% |
120,092
-25,295
| -17% | -$653K |
|
|
VXZ
322
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $3.34M | 0.05% |
63,550
| – | – |
|
|
CBAY
323
DELISTED
Cymabay Therapeutics
CBAY
| $3.33M | 0.05% |
+339,056
| New | +$2.73M |
|
324
PUT
MGM Resorts International
MGM
$11.7B
| $3.31M | 0.05% |
+155,000
| New | +$3.37M |
|
325
PUT
KB Home
KBH
$3.5B
| $3.31M | 0.05% |
+200,000
| New | +$3.21M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.